Matrix forming characteristics of inner and outer human meniscus cells on 3D collagen scaffolds under normal and low oxygen tensions

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Croutze, Roger ^a   Jomha, Nadr ^a   Uludag, Hasan ^a   Adesida, Adetola ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Collagen; Hypoxia; Meniscus; Meniscus fibrochondrocyte; Normoxia; Oxygen tension; Scaffold; Tissue engineering

Indexed keywords

AGGRECAN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; MESSENGER RNA; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CASE REPORT; CELL DEDIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KNEE MENISCUS; MIDDLE AGED; OXYGEN TENSION; PHENOTYPE; STIMULATION; TOTAL KNEE REPLACEMENT;

AGED; AGGRECANS; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE I; COLLAGEN TYPE II; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; MENISCI, TIBIAL; MIDDLE AGED; OXYGEN; PHENAZINES; PHENOTYPE; TISSUE SCAFFOLDS;

EID: 84890010923     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-353     Document Type: Article

References (44)

1. Function of the normal meniscus and consequences of meniscal resection. Aagaard H, Verdonk R, Scand J Med Sci Sports 1999 9 3 134 140 10380269
2. The consequences of meniscectomy. McDermott ID, Amis AA, J Bone Joint Surg Br 2006 88 12 1549 1556 17159163 (Pubitemid 44970679)
3. The knee meniscus: a complex tissue of diverse cells. Sanchez-Adams J, Cell Mol Bioeng 2009 2 332 340 10.1007/s12195-009-0066-6
4. Meniscus structure in human, sheep, and rabbit for animal models of meniscus repair. Chevrier A, Nelea M, Hurtig MB, Hoemann CD, Buschmann MD, J Orthop Res 2009 27 9 1197 1203 10.1002/jor.20869 19242978
5. Human meniscus cell: characterization of the primary culture and use for tissue engineering. Nakata K, Shino K, Hamada M, Mae T, Miyama T, Shinjo H, Horibe S, Tada K, Ochi T, Yoshikawa H, Clin Orthop Relat Res 2001 391 208 218 11603705
6. Development of the meniscus of the knee joint in human fetuses. Fukazawa I, Hatta T, Uchio Y, Otani H, Congenit Anom (Kyoto) 2009 49 1 27 32 10.1111/j.1741-4520.2008.00216.x 19243414
7. Microvasculature of the human meniscus. Arnoczky SP, Warren RF, Am J Sports Med 1982 10 2 90 95 10.1177/036354658201000205 7081532 (Pubitemid 12126962)
8. The microvasculature of the meniscus and its response to injury. An experimental study in the dog. Arnoczky SP, Warren RF, Am J Sports Med 1983 11 3 131 141 10.1177/036354658301100305 6688156 (Pubitemid 13090213)
9. The healing of semilunar cartilage. King D, J Bone Joint Surg 1936 18B 333 342
10. Treatment of meniscal injury: a current concept review. Gu YL, Wang YB, Chin J Traumatol 2010 13 6 370 376 21126396
11. The epidemiology of musculoskeletal tendinous and ligamentous injuries. Clayton RA, Court-Brown CM, Injury 2008 39 12 1338 1344 10.1016/j.injury.2008. 06.021 19036362
12. Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Berthiaume MJ, Raynauld JP, Martel-Pelletier J, Labonte F, Beaudoin G, Bloch DA, Choquette D, Haraoui B, Altman RD, Hochberg M, et al. Ann Rheum Dis 2005 64 4 556 563 10.1136/ard.2004.023796 15374855 (Pubitemid 40469084)
13. Knee osteoarthritis after meniscectomy: prevalence of radiographic changes after twenty-one years, compared with matched controls. Roos H, Lauren M, Adalberth T, Roos EM, Jonsson K, Lohmander LS, Arthritis Rheum 1998 41 4 687 693 10.1002/1529-0131(199804)41:4<687::AID-ART16>3.0.CO;2-2 9550478 (Pubitemid 28214987)
14. Total meniscectomy in adolescents: a 40-year follow-up. McNicholas MJ, Pengas IP, Assiotis A, Nash W, Hatcher J, Banks J, J Bone Joint Surg Br 2012 94 12 1649 1654 23188906
15. Knee joint changes after meniscectomy. Fairbank TJ, J Bone Joint Surg Br 1948 30B 4 664 670 18894618
16. Allograft meniscus transplantation. Lee AS, Kang RW, Kroin E, Verma NN, Cole BJ, Sports Med Arthrosc 2012 20 2 106 114 10.1097/JSA.0b013e318246f005 22555208
17. Repairs by trephination and suturing of longitudinal injuries in the avascular area of the meniscus in goats. Zhang Z, Arnold JA, Williams T, McCann B, Am J Sports Med 1995 23 1 35 41 10.1177/036354659502300106 7726348
18. Biological strategies to enhance healing of the avascular area of the meniscus. Longo UG, Campi S, Romeo G, Spiezia F, Maffulli N, Denaro V, Stem Cells Int 2012 2012 528359 22220179
19. Meniscal repair using an exogenous fibrin clot. An experimental study in dogs. Arnoczky SP, Warren RF, Spivak JM, J Bone Joint Surg Am 1988 70 8 1209 1217 3417706
20. Tissue engineering for total meniscal substitution: animal study in sheep model-results at 12 months. Kon E, Filardo G, Tschon M, Fini M, Giavaresi G, Marchesini Reggiani L, Chiari C, Nehrer S, Martin I, Salter DM, et al. Tissue Eng Part A 2012 18 15-16 1573 1582 22500654
21. Repair of meniscal lesions using a scaffold-free tissue-engineered construct derived from allogenic synovial MSCs in a miniature swine model. Moriguchi Y, Tateishi K, Ando W, Shimomura K, Yonetani Y, Tanaka Y, Kita K, Hart DA, Gobbi A, Shino K, et al. Biomaterials 2013 34 9 2185 2193 10.1016/j.biomaterials.2012.11.039 23261221
22. Demonstration of HLA and ABH antigens in fresh and frozen human menisci by immunohistochemistry. Khoury MA, Goldberg VM, Stevenson S, J Orthop Res 1994 12 6 751 757 10.1002/jor.1100120602 7983550 (Pubitemid 24377724)
23. Successful treatment of painful irreparable partial meniscal defects with a polyurethane scaffold: two-year safety and clinical outcomes. Verdonk P, Beaufils P, Bellemans J, Djian P, Heinrichs EL, Huysse W, Laprell H, Siebold R, Verdonk R, the Actifit Study G, Am J Sports Med 2012 40 4 844 853 10.1177/0363546511433032 22328711
24. Passage and reversal effects on gene expression of bovine meniscal fibrochondrocytes. Gunja NJ, Athanasiou KA, Arthritis Res Ther 2007 9 5 93 10.1186/ar2293 17854486 (Pubitemid 350081951)
25. The matrix-forming phenotype of cultured human meniscus cells is enhanced after culture with fibroblast growth factor 2 and is further stimulated by hypoxia. Adesida AB, Grady LM, Khan WS, Hardingham TE, Arthritis Res Ther 2006 8 3 61 10.1186/ar1929 16563175
26. Tissue engineering and regenerative medicine strategies in meniscus lesions. Pereira H, Frias AM, Oliveira JM, Espregueira-Mendes J, Reis RL, Arthroscopy 2011 27 12 1706 1719 10.1016/j.arthro.2011.08.283 22019234
27. Meniscus cells seeded in type I and type II collagen-GAG matrices in vitro. Mueller SM, Shortkroff S, Schneider TO, Breinan HA, Yannas IV, Spector M, Biomaterials 1999 20 8 701 709 10.1016/S0142-9612(98)00189-6 10353653 (Pubitemid 29176699)
28. Three-dimensional culture of human meniscal cells: extracellular matrix and proteoglycan production. Gruber HE, Mauerhan D, Chow Y, Ingram JA, Norton HJ, Hanley EN Jr, Sun Y, BMC Biotechnol 2008 8 54 10.1186/1472-6750-8-54 18582376 (Pubitemid 351959581)
29. Oxygen tension is a determinant of the matrix-forming phenotype of cultured human meniscal fibrochondrocytes. Adesida AB, Mulet-Sierra A, Laouar L, Jomha NM, PLoS One 2012 7 6 39339 10.1371/journal.pone.0039339 22720095
30. Cartilage tissue engineering: controversy in the effect of oxygen. Malda J, Martens DE, Tramper J, van Blitterswijk CA, Riesle J, Crit Rev Biotechnol 2003 23 3 175 194 14743989 (Pubitemid 38045804)
31. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Farndale RW, Buttle DJ, Barrett AJ, Biochim Biophys Acta 1986 883 2 173 177 10.1016/0304-4165(86)90306-5 3091074 (Pubitemid 16027978)
32. Human meniscus cells express hypoxia inducible factor-1alpha and increased SOX9 in response to low oxygen tension in cell aggregate culture. Adesida AB, Grady LM, Khan WS, Millward-Sadler SJ, Salter DM, Hardingham TE, Arthritis Res Ther 2007 9 4 69 10.1186/ar2267 17640365 (Pubitemid 47250409)
33. Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Khan WS, Adesida AB, Hardingham TE, Arthritis Res Ther 2007 9 3 55 10.1186/ar2211 17537234 (Pubitemid 46995584)
34. Chondrogenic differentiation of human bone marrow stem cells in transwell cultures: generation of scaffold-free cartilage. Murdoch AD, Grady LM, Ablett MP, Katopodi T, Meadows RS, Hardingham TE, Stem Cells 2007 25 11 2786 2796 10.1634/stemcells.2007-0374 17656642 (Pubitemid 350127863)
35. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 4 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
36. Regional multilineage differentiation potential of meniscal fibrochondrocytes: implications for meniscus repair. Mauck RL, Martinez-Diaz GJ, Yuan X, Tuan RS, Anat Rec (Hoboken) 2007 290 1 48 58 10.1002/ar.20419 17441197 (Pubitemid 46328083)
37. Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Martin I, Vunjak-Novakovic G, Yang J, Langer R, Freed LE, Exp Cell Res 1999 253 2 681 688 10.1006/excr.1999.4708 10585291 (Pubitemid 30003129)
38. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Barbero A, Ploegert S, Heberer M, Martin I, Arthritis Rheum 2003 48 5 1315 1325 10.1002/art.10950 12746904 (Pubitemid 36554530)
39. Dexamethasone enhances SOX9 expression in chondrocytes. Sekiya I, Koopman P, Tsuji K, Mertin S, Harley V, Yamada Y, Shinomiya K, Nifuji A, Noda M, J Endocrinol 2001 169 3 573 579 10.1677/joe.0.1690573 11375127 (Pubitemid 32536990)
40. Transcriptional mechanisms of chondrocyte differentiation. de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W, Matrix Biol 2000 19 5 389 394 10.1016/S0945-053X(00)00094-9 10980415
41. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. Sekiya I, Tsuji K, Koopman P, Watanabe H, Yamada Y, Shinomiya K, Nifuji A, Noda M, J Biol Chem 2000 275 15 10738 10744 10.1074/jbc.275.15.10738 10753864 (Pubitemid 30212701)
42. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Aigner T, Gebhard PM, Schmid E, Bau B, Harley V, Poschl E, Matrix Biol 2003 22 4 363 372 10.1016/S0945-053X(03)00049-0 12935820 (Pubitemid 36993761)
43. Hypoxia-inducible factor 1alpha inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1alpha-dependent redifferentiation of chondrocytes. Duval E, Leclercq S, Elissalde JM, Demoor M, Galera P, Boumediene K, Arthritis Rheum 2009 60 10 3038 3048 10.1002/art.24851 19790048
44. Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype. Lafont JE, Talma S, Murphy CL, Arthritis Rheum 2007 56 10 3297 3306 10.1002/art.22878 17907154 (Pubitemid 47585424)